Lung Cancers Terminated Phase 2 Trials for Afatinib (DB08916)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02271906The ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant SettingTreatment